Cantor Fitzgerald reaffirmed their overweight rating on shares of Aetna Inc. (NYSE:AET) in a report published on Wednesday, August 9th. The firm currently has a $175.00 price target on the stock, up from their prior price target of $150.00. Cantor Fitzgerald also issued estimates for Aetna’s FY2017 earnings at $9.50 EPS and FY2018 earnings at $10.10 EPS.
A number of other equities analysts also recently commented on the stock. Deutsche Bank AG raised their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a hold rating in a report on Monday, August 7th. Jefferies Group LLC reaffirmed a hold rating and set a $163.00 price objective (up from $157.00) on shares of Aetna in a report on Friday, August 4th. Royal Bank Of Canada raised their price objective on shares of Aetna from $162.00 to $171.00 and gave the stock an outperform rating in a report on Friday, August 4th. BidaskClub downgraded shares of Aetna from a buy rating to a hold rating in a report on Monday, July 31st. Finally, Credit Suisse Group reissued an outperform rating and set a $165.00 price target (up from $160.00) on shares of Aetna in a report on Thursday, July 13th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of $157.99.
Aetna (AET) traded down 0.87% on Wednesday, reaching $154.45. The company’s stock had a trading volume of 1,781,161 shares. Aetna has a 52 week low of $104.59 and a 52 week high of $161.69. The stock has a market capitalization of $51.29 billion, a P/E ratio of 34.28 and a beta of 0.54. The firm has a 50 day moving average price of $154.81 and a 200 day moving average price of $140.38.
Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. The company had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same period last year, the firm earned $2.21 EPS. On average, equities analysts anticipate that Aetna will post $9.55 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Aetna’s (AET) “Overweight” Rating Reiterated at Cantor Fitzgerald” was published by BNB Daily and is the property of of BNB Daily. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/aetna-inc-aet-stock-rating-reaffirmed-by-cantor-fitzgerald-updated.html.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,008,606.49. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.90% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the last quarter. Capital World Investors raised its position in shares of Aetna by 8.9% in the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares during the last quarter. FMR LLC raised its position in shares of Aetna by 73.8% in the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after buying an additional 5,833,567 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock worth $558,540,000 after buying an additional 165,278 shares during the last quarter. 91.69% of the stock is currently owned by hedge funds and other institutional investors.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.